ArticleTranslational medicine communications2023

A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors.

Joaquina C Baranda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.